Home Contraception Tags

View the Latest: Contraception

Filter

List Grid

41 - 50 of 64 Results

  • KFF Examines Key Considerations for the Implementation of Insurance Coverage for Over-the-Counter Contraceptives

    News Release

    With federal regulators seeking public input on the potential benefits, costs, and implementation considerations of requiring private health insurance plans to cover over-the-counter preventive products without a prescription, a new KFF post explores the issues relevant to covering over-the-counter contraceptives. These contraceptives include Opill, the first daily oral contraceptive pill to receive FDA approval for over-the-counter availability. The analysis draws on the lessons learned from KFF staff interviews with more than 80 key players nationally…

  • Considerations for Covering Over-the-Counter Contraception

    Policy Watch

    In October 2023, the Departments of the Treasury, Labor, and Health and Human Services issued a request for information to gather public input about the potential benefits, costs, and implementation considerations of requiring private health insurance plans to cover OTC preventive services and supplies without a prescription. This policy watch addresses key considerations for the implementation of insurance coverage for non-prescribed OTC contraceptives based on the lessons learned from KFF’s 2023 study of Insurance Coverage…

  • KFF Examines How Abortion Bans, Misinformation, and State Actions May Affect Access to Contraception

    News Release

    Following the Supreme Court’s ruling overturning Roe v. Wade, uncertainty has emerged over whether the right to contraception could also be limited. Justice Thomas’ concurring opinion in Dobbs renewed attention and raised the possibility that other Supreme Court precedents relying on the same principles as Roe, such as the right of people to obtain contraceptives, could also be overturned. In response, legislative bodies at the state and federal level have debated, and in some cases…

  • KFF Examines Challenges in Navigating Coverage for Opill, the First Over-the-Counter Daily Oral Contraceptive Pill, Coming to Market Next Year 

    News Release

    As Opill—the first over-the-counter daily oral contraceptive pill in the United States—is expected to be available for purchase in early 2024, new research conducted by KFF examines barriers to its accessibility for consumers and challenges in providing insurance coverage for it. Based on interviews with nearly 80 representatives from private insurance plans, state Medicaid programs, chain pharmacies, and other key groups, the report provides a deeper view into the operational challenges in expanding access to…

  • Insurance Coverage of OTC Oral Contraceptives: Lessons from the Field

    Report

    This report is based on 35 structured interviews conducted from January to August 2023, with nearly 80 experts and key players such as pharmacists, health plans, and state Medicaid officials involved in the coverage and provision of OTC contraception in seven states with one or more of these coverage approaches (IL, NJ, NM, NY, OR, UT, and WA). It discusses the challenges and successes in coverage under private health insurance and Medicaid and reviews policy…

  • KFF Health Misinformation Tracking Poll Pilot

    Poll Finding

    The poll reveals that at least four in ten U.S. adults saying they’ve heard each of 10 specific false claims about COVID-19, reproductive health, and gun violence. While relatively small shares definitely believes the false claims, many more are uncertain about them. The survey also examines the public’s social and traditional media use and trust in sources of health information.

  • A National Survey of OBGYNs’ Experiences After Dobbs

    Report

    This report, based on a nationally representative survey of office-based OBGYNs practicing in the United States, examines the provision of sexual and reproductive health care provided by OBGYNs before and after the Dobbs decision, comparing the experiences of OBGYNs practicing in states where abortion is fully banned, states with gestational restrictions, and states where abortion remains available under most circumstances.

  • New KFF National Survey of OBGYNs Finds Dobbs Decision Has Made It Harder to Treat Miscarriages and Other Pregnancy-Related Emergencies in Affected States; In States with Bans, Half Report Patients Who Were Unable to Obtain an Abortion They Sought

    News Release

    A new KFF survey of office-based OBGYNs finds widespread effects on their practices and patients since the Supreme Court’s decision in Dobbs v. Jackson Women’s Health Organization one year ago.  In states with abortion bans, half say that they have patients who have been unable to obtain an abortion, about four in ten say that they have faced constraints on their care for miscarriages and pregnancy-related emergencies, and six in ten (61%) express concerns about…

  • A Focus on Contraception in the Wake of Dobbs

    Perspective

    In this commentary for Women’s Health Issues, a publication of the Jacobs Institute of Women’s Health, KFF experts discuss contraceptive coverage and financing policies, access points within the delivery system, and the role of mis- and disinformation.